Debiopharm is a privately-held Swiss biopharmaceutical company mainly active in development and clinical testing of drug candidates.[1] It was founded in 1979 by Rolland-Yves Mauvernay. The company now has 2 sites in Lausanne and in Martigny, Switzerland with new building expansion projects in both locations.[2][3]
History
Rolland-Yves Mauvernay founded Debiopharm in 1979 in Martigny, Switzerland.[4] In 1981, the Cytotech laboratory was created and after a few years it became Debio Recherche Pharmaceutique (R.P.), then Debiopharm Research & Manufacturing. Initially, the company worked on interferon and, in 1982, it began to focus on triptorelin, after having acquired the rights for its development from Tulane University